Moneycontrol PRO
Upcoming Event:Super25 3.0- India’s Largest Online Stock Traders Conference brought to you by Moneycontrol Pro & Espresso

Accumulate Tatva Chintan Pharma Chem; target of Rs 2902 : KR Choksey

KR Choksey recommended accumulate rating on Tatva Chintan Pharma Chem with a target price of Rs 2902 in its research report dated January 19, 2022.

January 20, 2022 / 04:48 PM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

KR Choksey's research report on Tatva Chintan Pharma Chem


Revenue stood at INR 1,047Mn down by 15.3% QoQ (+30.6% YoY) on account of contraction in demand witnessed for its product segment ‘Structured Directing Agents’ (SDAs) that contributed 51% of revenue as against 62% in the previous quarter. EBITDA stood at INR 238Mn, degrew by -2.9% YoY (-33.7% QoQ) due to increased cost of sales by 40% YoY accompanied by rise in other expenses by 68% YoY. As a result, EBITDA margin declined to 22.75% vs. 30.6% in Q3FY21 (-786 bps YoY). PAT grew by 9.2% YoY at INR 228Mn (-29.6% QoQ). PAT margin reported at 21.8% declined by 427 bps YoY / 443 bps QoQ. EPS stood at INR 10.3 as against INR 10.39 / INR 14.62 in Q3FY21 / Q2FY22, respectively. TCPCL’s 9MFY22 performance posted strong growth in revenue, EBITDA and PAT at 75% / 107% / 152% on YoY basis, respectively. EBITDA and PAT margins stood at 25.5% / 23.4% as compared to 21.5% / 16.2% in 9MFY21, respectively.



Outlook


We assign PE multiple of 40.0x to FY24E EPS to arrive at our revised target price of INR 2,902 per share (old Target: INR 2,620) and reiterate our ACCUMULATE view on the stock.

Close

For all recommendations report, click here


Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.



Download your money calendar for 2022-23 here and keep your dates with your moneybox, investments, taxes

Broker Research
first published: Jan 20, 2022 04:48 pm
Sections
ISO 27001 - BSI Assurance Mark